Cancer Death Risk Up for Kidney Transplant, Dialysis Patients
THURSDAY, Feb. 14, 2019 -- Dialysis and kidney transplant patients have more than a 2.5-fold increased risk for cancer death, according to a study published online Feb. 14 in the Journal of the American Society of Nephrology. Eric H. Au, M.B.B.S.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2019 Category: Pharmaceuticals Source Type: news

Kidney Failure Patients Face Higher Risk of Cancer Death
THURSDAY, Feb. 14, 2019 -- Patients with kidney failure who are on dialysis or have received a transplant have a sharply higher risk of dying from cancer, Australian researchers report. In fact, compared with people who don't have kidney failure,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2019 Category: General Medicine Source Type: news

Becton Dickinson wins FDA 510(k) for Wavelinq 4F endoAVF system
Becton Dickinson (NYSE:BDX) said today that it won FDA 510(k) clearance for its WavelinQ 4 French endovascular arteriovenous fistula creation system. The Franklin Lakes, N.J.-based company said that the newly cleared WavelinQ 4F endoAVF system features improved technology that allows for the creation of an AVF in either the ulnar artery and ulnar vein or the radial artery and radial vein. The new ability expands upon the company’s existing indications for its WavelinQ 6F endoAVF system, BD said. “With BD WavelinQ 4F endoAVF system, I can provide my ESRD patients with two additional fistula location op...
Source: Mass Device - February 13, 2019 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Featured Food & Drug Administration (FDA) Regulatory/Compliance Vascular bectondickinson Source Type: news

Effects of Vadadustat on Hemoglobin in Hemodialysis Patients Effects of Vadadustat on Hemoglobin in Hemodialysis Patients
Vadadustat is a potential new treatment for anemia in chronic kidney disease -- but what do we know about its impacts in patients receiving hemodialysis?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2019 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Fresenius launches 2008T BlueStar hemodialysis machine in U.S.
Fresenius Medical Care (NYSE:FMS) said today that it launched its 2008T BlueStar hemodialysis machine, touting more than 30 improvements from previous device models. The Waltham, Mass.-based company said that the new system is intended to allow for simpler operation and maintenance with additional treatment options, and added that the system features a number of newly automated technologies. “The new and enhanced 2008T BlueStar hemodialysis machines provide more than 30 unique enhancements to better serve end stage renal disease patients undergoing dialysis. Our new machines represent a significant step for...
Source: Mass Device - February 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Dialysis Fresenius Source Type: news

Fresenius Medical Care North America Launches 2008T BlueStar(TM) Hemodialysis Machine Across the U.S.
Fresenius Medical Care North America Advances Renal Care with Next Generation Dialysis Delivery System Featuring More Than 30 Enhancements WALTHAM, Mass., Feb. 11, 2019 -- (Healthcare Sales & Marketing Network) -- Fresenius Medical Care North America's... Devices, Product Launch Fresenius Medical Care, 2008T BlueStar, hemodialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2019 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets USFDA nod for drug for patients on dialysis
The approved product is a generic version of Genzyme Corporation's Renagel tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 11, 2019 Category: Pharmaceuticals Source Type: news

CPR Not Always Given at Dialysis Clinics When Needed
FRIDAY, Feb. 8, 2019 -- When kidney failure patients undergoing treatment at dialysis clinics suffer cardiac arrest, the clinic staff usually jumps in to perform lifesaving CPR, but not always, a new study finds. " It is reassuring that bystander CPR... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 8, 2019 Category: General Medicine Source Type: news

CPR Not Always Given at Dialysis Clinics When Needed
Title: CPR Not Always Given at Dialysis Clinics When NeededCategory: Health NewsCreated: 2/8/2019 12:00:00 AMLast Editorial Review: 2/8/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 8, 2019 Category: Cardiology Source Type: news

Dialysis Staff-Initiated CPR Ups Outcomes in Cardiac Arrest
THURSDAY, Feb. 7, 2019 -- For patients with out-of-hospital cardiac arrest (OHCA) occurring in outpatient dialysis clinics, dialysis staff-initiated cardiopulmonary resuscitation (CPR) is associated with improved outcomes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2019 Category: Pharmaceuticals Source Type: news

Bone, Inflammation and the Bone Marrow Niche in CKD Bone, Inflammation and the Bone Marrow Niche in CKD
A new review investigates the potential link between bone, inflammation, and the bone marrow niche in chronic kidney disease.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2019 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Hemodialysis Facility Practices Linked to Patient Outcomes
TUESDAY, Feb. 5, 2019 -- Certain practices in hemodialysis facilities relating to management of fluid volume and intradialytic hypotension are associated with patient outcomes, according to a study published online Feb. 5 in the Clinical Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2019 Category: Pharmaceuticals Source Type: news

Behind the Invention: Wearable Artificial Kidney
If you've ever known someone who has had to be on dialysis, you know that the quality of life for dialysis patients is not great. First of all, there is a pill burden. "My patients need to eat 20 to 30 pills a day," Victor Gura, MD, an internist, nephrologist, and inventor of the Wearable Artificial Kidney (WAK) told MD&M West attendees on Tuesday. "So one was making a joke. He said 'I could put them in a bowl with some dressing and have a salad'. The bottom line is it's a burden and it's also expensive." In addition to the pill burden, dialysis patients are restricted in the...
Source: MDDI - February 5, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Design Source Type: news

Kenya: NHIF Records Increased Payouts for Kidney Illnesses
[Nation] National Hospital Insurance Fund payouts for treatment of kidney failure increased by 41 percent last year, with the agency releasing Sh1.8 billion for dialysis. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 5, 2019 Category: African Health Source Type: news

Peritoneal dialysis cost  saving versus haemodialysis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2019 Category: Drugs & Pharmacology Source Type: news

Fruit, Vegetable Intake Very Low in Hemodialysis Population
THURSDAY, Jan. 31, 2019 -- Fruit and vegetable intake is very low in the hemodialysis population, with higher consumption associated with lower mortality, according to a study published online Jan. 31 in the Clinical Journal of the American Society... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2019 Category: Pharmaceuticals Source Type: news

Laminate Medical brings in $12m for dialysis vascular support device
Israeli medtech start-up Laminate Medical Technologies said today that it raised $12 million in a new round of financing slated to support its VasQ vascular support device. The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The VasQ regulates flow by constraining and shaping optimal geometrical parameters of the fistula, the company said, and reinforces and shields the vulnerable perianastomotic vein against high pressure, wall tension and flow levels. The round was joined by Asahi Kasei (TYO:3407) and Tal Capital...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dialysis Featured Vascular Laminate Medical Technologies Source Type: news

Israeli Start-up Laminate, Developer of a Vascular Support Solution for Dialysis Patients, Has Completed a Capital Raising Round of $12 Million
Among the investors in the current round are the Japanese company Asahi Kasei Medical, one of the largest manufacturers of dialyzers in the world, and private investors such as Shai Agassi, Mickey Boodaei, Yuval Tal, and Meir Barel Laminate has begun cl... Devices, Venture Capital Laminate Medical Technologies, VasQ, vascular access, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2019 Category: Pharmaceuticals Source Type: news

Dialysis nurse donates her own KIDNEY to a poorly stranger in desperate need of a transplant  
Rachel Cox, 48, has worked on a renal unit in Ayrshire, Scotland, for years. Her family said she was 'crazy', but the mother-of-two underwent the operation in 2017. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2019 Category: Consumer Health News Source Type: news

Is Vitamin D3 Bad for the Kidney? Is Vitamin D3 Bad for the Kidney?
The question of whether vitamin D3 negatively impacts kidney function is complex. This editorial explores the issue.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2019 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

U.S. gov ’ t shutdown again delays closing for Fresenius-NxStage merger
Fresenius (NYSE:FMS) said today that an interruption to the FTC’s review of its merger NxStage Medical (NSDQ:NXTM), caused by the partial U.S. government shutdown, has again delayed the end-date of the deal which has now been extended to August 6, 2019. The end-date is not hard-set, Fresenius said, and could occur on an earlier date if there have been 60 consecutive days of full funding for the FTC, according to an SEC filing. Fresenius said that it already signed a consent decree proposed by the staff of the FTC, but that it remains to be approved by the FTC Commissioners. Under the terms of the ...
Source: Mass Device - January 29, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dialysis Mergers & Acquisitions Fresenius NxStage Medical Inc. Source Type: news

Benefits, Barriers to Exercise Examined for Patients With ESKD
TUESDAY, Jan. 29, 2019 -- Patients with end-stage kidney disease (ESKD) undergoing maintenance dialysis express a desire to exercise to regain energy and strength, but many report barriers to exercise, according to a study published online Jan. 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2019 Category: Pharmaceuticals Source Type: news

Flu Season Tough on ESRD Patients
(MedPage Today) -- Researchers recommend flu vaccines for all patients on dialysis (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 24, 2019 Category: Infectious Diseases Source Type: news

Shared Decision Making Lacking for Nondialysis Kidney Care Shared Decision Making Lacking for Nondialysis Kidney Care
More patient-centered models of care are needed to support patients with advanced kidney disease who decide against dialysis, new data show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news

Dialysis in Advanced CKD: Clinicians Won't Take No for an Answer
(MedPage Today) -- Resistance,'browbeating'seen when patients opt against dialysis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 22, 2019 Category: Primary Care Source Type: news

Elderly who don't want dialysis often pressured to get it
(Reuters Health) - Doctors tend to steer elderly people with failing kidneys toward dialysis even when patients say they'd rather avoid such treatments, a new study finds. And when patients decline dialysis, which wouldn't buy much more time for a frail, elderly patient, doctors often try to convince them to change their minds, the study shows. (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Baxter acquires software developer True Process
Baxter (NYSE:BAX) said last week that it acquired healthcare software developer True Process. The company’s Vines software platform is designed for bedside data collection and normalization, according to a report from BizTimes. Founder Todd Dunsirn, who reportedly left the firm after the acquisition closed, told BizTimes that the company’s software aims to connect the various devices that monitor and collect patient-related data in a hospital. At one time, True Process had roughly 50 employees – half of whom worked remotely for client ICU Medical – and pulled in $10 million in revenue. Most of ...
Source: Mass Device - January 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Hospital Care Mergers & Acquisitions Software / IT Wall Street Beat Baxter Source Type: news

Mass. company plans $4.4M kidney dialysis project, eyeing opportunity in Metro East
A facility is planned for Granite City, Illinois in 2020. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 21, 2019 Category: Pharmaceuticals Authors: Brian Robbins Source Type: news

Mass. company plans $4.4M kidney dialysis project, eyeing opportunity in Metro East
A facility is planned for Granite City, Illinois in 2020. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 21, 2019 Category: Biotechnology Authors: Brian Robbins Source Type: news

Can a Polymer Help Reduce Deaths from Sepsis?
Sepsis is one of the leading causes of death in hospitals, and incidences are on the rise, according to the National Institute of General Medical Sciences (NIGMS). Two independent cohort studies published in JAMA found that sepsis contributed to 1 in every 2 to 3 deaths.1 Harshu Musunuri wants to help prevent such deaths. Majoring in Chemical Engineering at Stanford, the 18-year-old student is developing a synthetic (polymer) material that could act as both a diagnostic and a therapeutic agent for the bacterial toxins involved in the infections associated with sepsis. She has just won the first Pion...
Source: MDDI - January 19, 2019 Category: Medical Devices Authors: Daphne Allen Tags: R & D Source Type: news

VA completes ICU project
The VA Western New York Healthcare System has completed a $733,205 intensive care unit renovation project at its Buffalo center. The unit provides specialized treatment services, including post-operative cardiac care, dialysis, cardiac procedures and ventilator support. The 12,000-square-foot project saw renovations in a 15-bed unit that cares for critically ill and complex patients. The project included new lighting, pa tient lifts, telemetry and fire alarm upgrades, as well as aesthetic work… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 18, 2019 Category: Health Management Authors: Tracey Drury Source Type: news

JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he led the company through an initial public offering in 2005 and an acquisition by Johnson & Johnson in 2010. He has also held positions at Solace Therapeutics and Endonetics, Irvine, Calif.-based JenaValve said. “I am plea...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured apyxmedical biogennix Cardiac Dimensions Cardiovascular Systems Inc. Coorstek Covidien DaVita Inc. Digirad Corp. Endologix ev3 Inc. Integra LifeSciences Intuitive Surgical InVivo Therapeutics Source Type: news

Methicillin-Resistant Staphylococcus aureus (MRSA) | Medscape Methicillin-Resistant Staphylococcus aureus (MRSA) | Medscape
Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by S aureus bacteria and can be fatal. There are 2 major strains of MRSA: hospital-acquired (HA) MRSA and community-acquired (CA) MRSA. HA-MRSA includes cases in which the patient has had a current or recent hospitalization, receives dialysis, resides in a long-term care facility, or has had recent antibiotic use. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 14, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news

Another Device Gets Added to the Peritoneal Dialysis Mix
AWAK Technologies has been granted a breakthrough device designation from FDA for a wearable and ultra-portable peritoneal dialysis (PD) device. The Singapore-based company’s AWAK PD device allows dialysis to be performed "on-the-go", overcoming the challenge of long hours of therapy and connection to large-size dialysis machines, currently faced by renal patients. The company said FDA’s designation was granted after reviewing the results from the First-In-Human safety trial of AWAK PD device, which was successfully completed in October 2018 at the Singapore General Hospital, S...
Source: MDDI - January 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Awak Technologies wins FDA breakthrough designation for portable PD device
Awak Technologies said today that it won a breakthrough device designation from the FDA for its wearable Awak Peritoneal Dialysis system. The Awak PD system is a portable, wearable peritoneal dialysis system which allows dialysis to be performed “on-the-go”, the Singapore-based company said. The breakthrough designation was granted based on results from the first-in-human safety trial of the Awak PD device, which completed last October. Data from the trial indicates that the system was able to efficiently remove the accumulation of toxins from the body with no serious adverse events experienced by patients usin...
Source: Mass Device - January 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Food & Drug Administration (FDA) Regulatory/Compliance Awak Technologies Pte. Source Type: news

USFDA grants breakthrough designation for AWAK ’s Peritoneal Dialysis device
Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK ’s patented sorbent technology. (Source: mobihealthnews)
Source: mobihealthnews - January 11, 2019 Category: Information Technology Source Type: news

New Data Boosts Value Proposition of AlloSure
When our kidneys fail to function as they should, our treatment options generally begin with dialysis and end with a kidney transplant. Unfortunately, transplanted kidneys last, on average, between 12 years and 15 years (depending on if the donor is living or deceased, and if they are a relative or not). Some recipients are lucky if they even get five good years out of their transplanted kidney. CareDx has already established the clinical value of AlloSure, a donor-derived cell-free DNA test designed to assess allograft health in kidney transplant patients, and new data demonstrates the test's clinical utility in patients ...
Source: MDDI - January 9, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: IVD Source Type: news

Namibia: 'Bacteria Water' Threatens Opening of Dialysis Centre
[New Era] Katima Mulilo -The opening of a dialysis centre in Katima Mulilo to provide treatment to patients with renal failure has been put on hold after the town's water tested positive for bacteria. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 9, 2019 Category: African Health Source Type: news

Baxter launches on-demand peritoneal dialysis solution device trial
Baxter (NYSE:BAX) said yesterday that it launched an FDA-cleared clinical trial of its on-demand peritoneal dialysis solution generation system intended to allow patients to make peritoneal dialysis solutions in small batches at home. The system is designed to use a small water filtration device, concentrates and Deerfield, Ill.-based Baxter’s Amia automated peritoneal dialysis system to turn a patient’s tap water into dialysis solution as needed for therapy sessions. Baxter said that it has enrolled the first patient in the trial, which looks to assess the efficacy and safety of the new system for pa...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Dialysis Baxter Source Type: news

Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves – January 8, 2019
Insulet (NSDQ:PODD) said yesterday that it tapped former Medtronic minimally invasive therapies CFO and finance VP Wayde McMillan as its new chief financial officer, replacing Michael Levitz. The Acton, Mass.-based diabetes-focused medtech company said that McMillan will join the company in February and that Levitz will continue as an advisor for a period following the succession to ensure a smooth transition. McMillan will officially take the role of CFO on March 1. Prior to joining Insulet, McMillan held executive roles in finance at Medtronic, having come to the company during its acquisition of Covidien in 2015. After ...
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured AxoGen Bonesupport Cerus Corp. GI Dynamics Insulet Livongo Medidata Solutions Medtronic pressaomedical quantadialysistech Reva Medical Inc. Senseonics Smith & Nephew taelifesciences wrightme Source Type: news

Vitamin D may decrease mortality risk in patients on dialysis
Higher levels of vitamin D may lower the risk of death in patients on dialysis, according to a study published inNephrology Dialysis Transplantation. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 4, 2019 Category: Endocrinology Source Type: news

Thousands of Women Are Born Without a Uterus. A New Procedure Offers Them Hope
On an afternoon in November, a couple hosted a birthday party for their 1-year-old son. As family and friends gathered around the child to sing “Happy Birthday,” his parents addressed a milestone that reached well beyond the room. “It was emotional,” recalls the mother. “It took a lot more than a nine-month pregnancy to get him, and we wouldn’t be where we are without everyone’s support.” Many parents will tell you their child is miraculous. But the mere existence of this particular boy, who just a month earlier had taken his first steps, brings the miracle somehow closer to ...
Source: TIME: Health - January 3, 2019 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized fertility Research Source Type: news

Thousands of Women Are Born Without a Uterus. A New Procedure Offers Them Hope
On an afternoon in November, a couple hosted a birthday party for their 1-year-old son. As family and friends gathered around the child to sing “Happy Birthday,” his parents addressed a milestone that reached well beyond the room. “It was emotional,” recalls the mother. “It took a lot more than a nine-month pregnancy to get him, and we wouldn’t be where we are without everyone’s support.” Many parents will tell you their child is miraculous. But the mere existence of this particular boy, who just a month earlier had taken his first steps, brings the miracle somehow closer to ...
Source: TIME: Science - January 3, 2019 Category: Science Authors: Alexandra Sifferlin Tags: Uncategorized fertility Research Source Type: news

Scheduled Dialysis for Undocumented Immigrants Saves Money and Lives Scheduled Dialysis for Undocumented Immigrants Saves Money and Lives
Providing scheduled dialysis for undocumented immigrants with kidney failure, rather than offering them only emergency dialysis, dramatically reduces deaths, healthcare use and costs, a study from Texas suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 31, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Fresenius still awaiting FTC approval for NxStage acquisition
Fresenius (NYSE:FMS) said last Friday that it is still in the process of seeking approval from the U.S. Federal Trade Commission for its $2 billion merger with NxStage Medical (NSDQ:NXTM). The tie-up, which was delayed by NxStage in October in light of the FTC investigation, has been in the works for nearly a year and a half, having originally been announced last August. In an update released late last week, Fresenius Medical Care said that it is still seeking approval from the agency, and that it expects the acquisition to close early next year, according to a press release. The hoped-for closing date was p...
Source: Mass Device - December 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dialysis Featured Mergers & Acquisitions Wall Street Beat Fresenius NxStage Medical Inc. Source Type: news

Outcomes after toxic alcohol poisoning: a systematic review protocol - Wang C, Samaha D, Hiremath S, Sikora L, Sood MM, Kanji S, Clark EG.
BACKGROUND: Toxic alcohols have been implicated in accidental ingestions and intentional exposures. Recognition of toxic alcohol poisoning is challenging. The main treatment modalities include antidotes with alcohol dehydrogenase inhibitors and dialysis. C... (Source: SafetyLit)
Source: SafetyLit - December 31, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Scheduled dialysis for undocumented immigrants saves money and lives
(Reuters Health) - Providing scheduled dialysis for undocumented immigrants with kidney failure, rather than offering them only emergency dialysis, dramatically reduces deaths, healthcare use and costs, a study in Texas suggests. (Source: Reuters: Health)
Source: Reuters: Health - December 28, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics
The primary objective of this study was to determine the correlation between procalcitonin values and illness severity by evaluating the degree of end organ dysfunction using the Sequential Organ Failure Assessment score, length of stay and the severity of sepsis (sepsis alone vs. septic shock), The hypothesis that procalcitonin values would be higher in sicker patients was formulated before data collection began. Secondary outcomes studied in relation to procalcitonin levels included infection characteristics such as the site of infection, microbial agent and dialysis dependent CKD. Procalcitonin has a higher specificity ...
Source: Current Awareness Service for Health (CASH) - December 28, 2018 Category: Consumer Health News Source Type: news

CMS: Medicare Program: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) and Fee Schedule Amounts, and Technical Amendments to Correct Existing Regulations Related to the CBP for Certain DMEPOS; Correction
Notice from the Centers for Medicare and Medicaid (CMS) correcting typographical and technical errors to a final rulepublished on November 14, 2018. Corrections go into effect January 1, 2019. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - December 28, 2018 Category: Rural Health Source Type: news

Novel Oral Anticoagulants in Patients With CKD and AF Novel Oral Anticoagulants in Patients With CKD and AF
Novel oral anticoagulants are often used in patients with chronic kidney disease and atrial fibrillation, but what do we know about the benefits and risks of these agents in this population?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 27, 2018 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news